NO893471L - Antidepressive n-substituerte nikotinamidforbindelser. - Google Patents

Antidepressive n-substituerte nikotinamidforbindelser.

Info

Publication number
NO893471L
NO893471L NO89893471A NO893471A NO893471L NO 893471 L NO893471 L NO 893471L NO 89893471 A NO89893471 A NO 89893471A NO 893471 A NO893471 A NO 893471A NO 893471 L NO893471 L NO 893471L
Authority
NO
Norway
Prior art keywords
chlorine
fluorine
compounds
antidepressive
methoxy
Prior art date
Application number
NO89893471A
Other languages
English (en)
Other versions
NO893471D0 (no
Inventor
Nicholas Alex Saccomano
Fredric James Vinick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO893471D0 publication Critical patent/NO893471D0/no
Publication of NO893471L publication Critical patent/NO893471L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)

Abstract

Visse N-substituerte nikotinamid-forbindelser med formel (I). og farmasøytisk akseptable syreaddisjonssalter derav hvor Rer 1-piperidyl, 1-(3-indolyl)etyl, Calkyl, fenyl, 1-(1-fenyletyl), benzyl eller mono-substituert benzyl, hvor substituenten er metyl, metoksy, klor eller fluor; og Rer bicyklo[2.2.1]hept-2-yl eller. hvor Y er hydrogen, fluor eller klor; og. X er hydrogen, fluor, klor, metoksy, trifluormetyl, cyano, karboksy, karboCC^alkoksy) , metylkarbamoyl eller dimetyl-karbamoyl virker som selektive nemmere av kalsium-uavhengig fosfodiesterase og er egnet som antidepressive midler.Fremgangsmåter for fremstilling av forbindelsene er beskrevet.
NO89893471A 1988-08-31 1989-08-30 Antidepressive n-substituerte nikotinamidforbindelser. NO893471L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/238,951 US4861891A (en) 1988-08-31 1988-08-31 Antidepressant N-substituted nicotinamide compounds

Publications (2)

Publication Number Publication Date
NO893471D0 NO893471D0 (no) 1989-08-30
NO893471L true NO893471L (no) 1990-03-01

Family

ID=22899998

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893471A NO893471L (no) 1988-08-31 1989-08-30 Antidepressive n-substituerte nikotinamidforbindelser.

Country Status (18)

Country Link
US (1) US4861891A (no)
EP (1) EP0357316B1 (no)
JP (1) JPH02115168A (no)
KR (1) KR920000760B1 (no)
AT (1) ATE88182T1 (no)
AU (1) AU609329B2 (no)
CA (1) CA1329605C (no)
DE (1) DE68905979T2 (no)
DK (1) DK426889A (no)
FI (1) FI894066L (no)
HU (1) HU208120B (no)
IE (1) IE892775L (no)
IL (1) IL91417A0 (no)
MY (1) MY104179A (no)
NO (1) NO893471L (no)
NZ (1) NZ230493A (no)
PT (1) PT91580B (no)
ZA (1) ZA896626B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973597A (en) * 1989-06-30 1990-11-27 Eli Lilly And Company Anticonvulsant agents
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
TW429148B (en) * 1995-10-27 2001-04-11 Pfizer Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
CA2285548C (en) * 1997-04-04 2006-07-11 Pfizer Products Inc. Nicotinamide derivatives
GB9715584D0 (en) * 1997-07-23 1997-10-01 Eisai Co Ltd Compounds
CZ20022413A3 (cs) 2000-01-31 2003-08-13 Pfizer Products Inc. Pyrimidinkarboxamidy užitečné jako inhibitory isozymů PDE4
HUP0204262A2 (hu) * 2000-01-31 2003-04-28 Pfizer Products Inc. Benzogyűrűvel kondenzált heterociklusos csoportot tartalmazó nikotinamid-származékok, továbbá e vegyületeket tartalmazó, a PDE4 izozimek szelektív gátlására adható gyógyászati készítmények
KR100661081B1 (ko) * 2000-06-10 2006-12-26 동화약품공업주식회사 항바이러스제로 유용한 6-메틸니코틴아미드 유도체
KR20030070150A (ko) 2001-01-31 2003-08-27 화이자 프로덕츠 인크. Ｐｄｅ4 이소자임 억제제로서 유용한 에테르 유도체
US7250518B2 (en) * 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CZ20031903A3 (cs) 2001-01-31 2004-07-14 Pfizer Products Inc. Amidové deriváty thiazolyl-, oxazolyl-, pyrrolyl- a imidazolyl karboxylových kyselin užitečné jako inhibitory isozymů PDE4
WO2002060875A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
US20050079548A1 (en) * 2003-07-07 2005-04-14 Plexxikon, Inc. Ligand development using PDE4B crystal structures
GB0317472D0 (en) * 2003-07-25 2003-08-27 Pfizer Ltd Nicotinamide derivatives useful as PDE4 inhibitors
JP2008503446A (ja) * 2004-05-06 2008-02-07 プレキシコン，インコーポレーテッド Ｐｄｅ４ｂ阻害剤及びその使用
CN101048407A (zh) * 2004-09-03 2007-10-03 普莱希科公司 双环杂芳基pde4b抑制剂
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
JP5374157B2 (ja) * 2005-11-24 2013-12-25 ドムペ・ファ．ル．マ・ソチエタ・ペル・アツィオーニ （ｒ）−アリールアルキルアミノ誘導体類と、それらを含有する薬剤組成物
WO2007098352A2 (en) * 2006-02-16 2007-08-30 Boehringer Ingelheim International Gmbh Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
DE102007057089B4 (de) * 2006-12-22 2010-04-29 Lg Display Co., Ltd. Flüssigkristallanzeige mit Photosensor und Herstellungsverfahren derselben
WO2008112164A2 (en) 2007-03-08 2008-09-18 The Board Of Trustees Of The Leland Stanford Junior University Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
WO2010028175A1 (en) 2008-09-08 2010-03-11 The Board Of Trustees Of The Leland Stanford Junior University Modulators of aldehyde dehydrogenase activity and methods of use thereof
JP2012506856A (ja) 2008-10-28 2012-03-22 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ アルデヒドデヒドロゲナーゼのモジュレーターおよびその使用方法
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2012149106A1 (en) 2011-04-29 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for increasing proliferation of adult salivary stem cells
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
KR20150135332A (ko) 2013-03-14 2015-12-02 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251263A (en) * 1979-09-04 1981-02-17 Stauffer Chemical Company N-substituted, 2-phenoxynicotinamide compounds and the herbicidal use thereof
US4270946A (en) * 1979-10-01 1981-06-02 Stauffer Chemical Company N-Aryl,2-phenoxy nicotinamide compounds and the herbicidal use thereof
IL64220A (en) * 1980-11-21 1985-06-30 May & Baker Ltd Nicotinamide derivatives,their preparation and their use as herbicides
US4692185A (en) * 1986-01-13 1987-09-08 Stauffer Chemical Company N-(ortho-substituted) benzyl, 3-trifluoromethylphenoxy nicotinamides as herbicides

Also Published As

Publication number Publication date
DK426889A (da) 1990-03-01
IL91417A0 (en) 1990-04-29
ATE88182T1 (de) 1993-04-15
PT91580B (pt) 1995-05-04
NO893471D0 (no) 1989-08-30
DE68905979T2 (de) 1993-07-22
DE68905979D1 (de) 1993-05-19
HUT52058A (en) 1990-06-28
FI894066A7 (fi) 1990-03-01
EP0357316B1 (en) 1993-04-14
KR920000760B1 (ko) 1992-01-21
MY104179A (en) 1994-02-28
AU609329B2 (en) 1991-04-26
DK426889D0 (da) 1989-08-30
EP0357316A1 (en) 1990-03-07
JPH02115168A (ja) 1990-04-27
AU4091389A (en) 1990-06-28
FI894066L (fi) 1990-03-01
IE892775L (en) 1990-02-28
ZA896626B (en) 1991-04-24
KR900003154A (ko) 1990-03-23
NZ230493A (en) 1991-03-26
US4861891A (en) 1989-08-29
FI894066A0 (fi) 1989-08-30
CA1329605C (en) 1994-05-17
HU208120B (en) 1993-08-30
PT91580A (pt) 1990-03-08

Similar Documents

Publication Publication Date Title
HUT52058A (en) Process for producing n-substituted nicotinamide derivatives
WO2004052893A3 (en) Substituted dihydropyrano indole-3,4-dione derivatives and 3-oxoacetic acid substituted 2-hydroxymethylindole derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
AU2418188A (en) Therapeutic heterocyclic compounds
HUP9901820A2 (hu) 4-Amino-pirimidin-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
NO983711L (no) Azabicykliske estere av karbaminsyrer som er nyttige i terapi
GR3015616T3 (en) Aryl-heteroaryl-carbinol derivatives having an analgesic activity.
WO2003031442A1 (en) Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
MX9800718A (es) Derivados de 2-(4-substituidos)-bencilamino-2-metil- propanamida.
AU2413995A (en) Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
ATE71617T1 (de) Chinolinonderivate, ihre herstellung und ihre verwendung als arzneimittel.
ES8506652A1 (es) Un metodo de preparar dihidrobenzopirrolbenzodiazepinas
ATE17346T1 (de) Benzamido-derivate.
NO159794C (no) Analogifremgangsm te ved fremstilling av terapeutisk virksomme 7-substituerte theofyllinderivater.
DK591488D0 (da) 1-acyl-3-oe4-(2-pyrimidinyl)-1-piperazinylaapropan-forbindelser, deres anvendelse til fremstilling af et angstdaempende laegemiddel og farmaceutiske praeparater indeholdende disse forbindelser
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
EA200001009A1 (ru) Производные пиридина, ингибирующие фосфодиэстеразу iv
NO954091L (no) 1,5-Benzodinazepinderivater med CCK- og/eller gastrinantagonistisk aktivitet
NO20052360L (no) Forbedrede formuleringer inneholdende substituerte imidazolderivater
DK413188D0 (da) Benzimidazol-derivater til terapeutisk anvendelse og fremgangsmaade til fremstilling deraf
TW340844B (en) Amide derivatives
DK87383A (da) Basisk substituerede 4-phenyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridiner, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse forbindelser
EP0017352A3 (en) Chromanone derivatives, a process for their preparation, compositions containing them
NO893039L (no) Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler.
EP0244085A3 (en) 3-(2-aminoethyl)indole derivatives
ES2058542T3 (es) Imidas biciclicas puenteadas de 4-(4-(3-benzoisotiazolil)-1-piperazinil)butilo antipsicoticas.